ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dystrophin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-4F9628
Home | Market Reports | Health| Pharmacy
Global Dystrophin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dystrophin Market Research Report 2025

Code: QYRE-Auto-4F9628
Report
September 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd

Dystrophin Market

The global market for Dystrophin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Dystrophin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dystrophin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dystrophin include Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, Editas Medicine Inc, Genethon SA, Nippon Shinyaku Co Ltd, Pfizer Inc, Sarepta Therapeutics Inc, WAVE Life Sciences Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dystrophin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dystrophin.
The Dystrophin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dystrophin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dystrophin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dystrophin Market Report

Report Metric Details
Report Name Dystrophin Market
Segment by Type
  • DS-5141
  • Biostrophin
  • BMBD-001
  • NS-065
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, Editas Medicine Inc, Genethon SA, Nippon Shinyaku Co Ltd, Pfizer Inc, Sarepta Therapeutics Inc, WAVE Life Sciences Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dystrophin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dystrophin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dystrophin Market report?

Ans: The main players in the Dystrophin Market are Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, Editas Medicine Inc, Genethon SA, Nippon Shinyaku Co Ltd, Pfizer Inc, Sarepta Therapeutics Inc, WAVE Life Sciences Ltd

What are the Application segmentation covered in the Dystrophin Market report?

Ans: The Applications covered in the Dystrophin Market report are Genetic Disorders, Musculoskeletal Disorders, Others

What are the Type segmentation covered in the Dystrophin Market report?

Ans: The Types covered in the Dystrophin Market report are DS-5141, Biostrophin, BMBD-001, NS-065, Others

Recommended Reports

Musculoskeletal Diseases

Cell And Gene Therapy

Genetic And Rare Diseases

1 Dystrophin Market Overview
1.1 Product Definition
1.2 Dystrophin by Type
1.2.1 Global Dystrophin Market Value Comparison by Type (2024 VS 2031)
1.2.2 DS-5141
1.2.3 Biostrophin
1.2.4 BMBD-001
1.2.5 NS-065
1.2.6 Others
1.3 Dystrophin by Application
1.3.1 Global Dystrophin Market Value by Application (2024 VS 2031)
1.3.2 Genetic Disorders
1.3.3 Musculoskeletal Disorders
1.3.4 Others
1.4 Global Dystrophin Market Size Estimates and Forecasts
1.4.1 Global Dystrophin Revenue 2020-2031
1.4.2 Global Dystrophin Sales 2020-2031
1.4.3 Global Dystrophin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dystrophin Market Competition by Manufacturers
2.1 Global Dystrophin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dystrophin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dystrophin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dystrophin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dystrophin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dystrophin, Product Type & Application
2.7 Global Key Manufacturers of Dystrophin, Date of Enter into This Industry
2.8 Global Dystrophin Market Competitive Situation and Trends
2.8.1 Global Dystrophin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dystrophin Players Market Share by Revenue
2.8.3 Global Dystrophin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dystrophin Market Scenario by Region
3.1 Global Dystrophin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dystrophin Sales by Region: 2020-2031
3.2.1 Global Dystrophin Sales by Region: 2020-2025
3.2.2 Global Dystrophin Sales by Region: 2026-2031
3.3 Global Dystrophin Revenue by Region: 2020-2031
3.3.1 Global Dystrophin Revenue by Region: 2020-2025
3.3.2 Global Dystrophin Revenue by Region: 2026-2031
3.4 North America Dystrophin Market Facts & Figures by Country
3.4.1 North America Dystrophin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dystrophin Sales by Country (2020-2031)
3.4.3 North America Dystrophin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dystrophin Market Facts & Figures by Country
3.5.1 Europe Dystrophin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dystrophin Sales by Country (2020-2031)
3.5.3 Europe Dystrophin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dystrophin Market Facts & Figures by Region
3.6.1 Asia Pacific Dystrophin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dystrophin Sales by Region (2020-2031)
3.6.3 Asia Pacific Dystrophin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dystrophin Market Facts & Figures by Country
3.7.1 Latin America Dystrophin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dystrophin Sales by Country (2020-2031)
3.7.3 Latin America Dystrophin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dystrophin Market Facts & Figures by Country
3.8.1 Middle East and Africa Dystrophin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dystrophin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dystrophin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dystrophin Sales by Type (2020-2031)
4.1.1 Global Dystrophin Sales by Type (2020-2025)
4.1.2 Global Dystrophin Sales by Type (2026-2031)
4.1.3 Global Dystrophin Sales Market Share by Type (2020-2031)
4.2 Global Dystrophin Revenue by Type (2020-2031)
4.2.1 Global Dystrophin Revenue by Type (2020-2025)
4.2.2 Global Dystrophin Revenue by Type (2026-2031)
4.2.3 Global Dystrophin Revenue Market Share by Type (2020-2031)
4.3 Global Dystrophin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dystrophin Sales by Application (2020-2031)
5.1.1 Global Dystrophin Sales by Application (2020-2025)
5.1.2 Global Dystrophin Sales by Application (2026-2031)
5.1.3 Global Dystrophin Sales Market Share by Application (2020-2031)
5.2 Global Dystrophin Revenue by Application (2020-2031)
5.2.1 Global Dystrophin Revenue by Application (2020-2025)
5.2.2 Global Dystrophin Revenue by Application (2026-2031)
5.2.3 Global Dystrophin Revenue Market Share by Application (2020-2031)
5.3 Global Dystrophin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Asklepios BioPharmaceutical Inc
6.1.1 Asklepios BioPharmaceutical Inc Company Information
6.1.2 Asklepios BioPharmaceutical Inc Description and Business Overview
6.1.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio
6.1.5 Asklepios BioPharmaceutical Inc Recent Developments/Updates
6.2 BioMarin Pharmaceutical Inc
6.2.1 BioMarin Pharmaceutical Inc Company Information
6.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
6.2.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioMarin Pharmaceutical Inc Dystrophin Product Portfolio
6.2.5 BioMarin Pharmaceutical Inc Recent Developments/Updates
6.3 Daiichi Sankyo Company Ltd
6.3.1 Daiichi Sankyo Company Ltd Company Information
6.3.2 Daiichi Sankyo Company Ltd Description and Business Overview
6.3.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Daiichi Sankyo Company Ltd Dystrophin Product Portfolio
6.3.5 Daiichi Sankyo Company Ltd Recent Developments/Updates
6.4 Editas Medicine Inc
6.4.1 Editas Medicine Inc Company Information
6.4.2 Editas Medicine Inc Description and Business Overview
6.4.3 Editas Medicine Inc Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Editas Medicine Inc Dystrophin Product Portfolio
6.4.5 Editas Medicine Inc Recent Developments/Updates
6.5 Genethon SA
6.5.1 Genethon SA Company Information
6.5.2 Genethon SA Description and Business Overview
6.5.3 Genethon SA Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Genethon SA Dystrophin Product Portfolio
6.5.5 Genethon SA Recent Developments/Updates
6.6 Nippon Shinyaku Co Ltd
6.6.1 Nippon Shinyaku Co Ltd Company Information
6.6.2 Nippon Shinyaku Co Ltd Description and Business Overview
6.6.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nippon Shinyaku Co Ltd Dystrophin Product Portfolio
6.6.5 Nippon Shinyaku Co Ltd Recent Developments/Updates
6.7 Pfizer Inc
6.7.1 Pfizer Inc Company Information
6.7.2 Pfizer Inc Description and Business Overview
6.7.3 Pfizer Inc Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Inc Dystrophin Product Portfolio
6.7.5 Pfizer Inc Recent Developments/Updates
6.8 Sarepta Therapeutics Inc
6.8.1 Sarepta Therapeutics Inc Company Information
6.8.2 Sarepta Therapeutics Inc Description and Business Overview
6.8.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sarepta Therapeutics Inc Dystrophin Product Portfolio
6.8.5 Sarepta Therapeutics Inc Recent Developments/Updates
6.9 WAVE Life Sciences Ltd
6.9.1 WAVE Life Sciences Ltd Company Information
6.9.2 WAVE Life Sciences Ltd Description and Business Overview
6.9.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 WAVE Life Sciences Ltd Dystrophin Product Portfolio
6.9.5 WAVE Life Sciences Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dystrophin Industry Chain Analysis
7.2 Dystrophin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dystrophin Production Mode & Process Analysis
7.4 Dystrophin Sales and Marketing
7.4.1 Dystrophin Sales Channels
7.4.2 Dystrophin Distributors
7.5 Dystrophin Customer Analysis
8 Dystrophin Market Dynamics
8.1 Dystrophin Industry Trends
8.2 Dystrophin Market Drivers
8.3 Dystrophin Market Challenges
8.4 Dystrophin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
List of Tables
 Table 1. Global Dystrophin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dystrophin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dystrophin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dystrophin Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Dystrophin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dystrophin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dystrophin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dystrophin Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dystrophin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dystrophin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dystrophin, Product Type & Application
 Table 12. Global Key Manufacturers of Dystrophin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dystrophin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dystrophin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dystrophin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dystrophin Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Dystrophin Sales Market Share by Region (2020-2025)
 Table 19. Global Dystrophin Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Dystrophin Sales Market Share by Region (2026-2031)
 Table 21. Global Dystrophin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dystrophin Revenue Market Share by Region (2020-2025)
 Table 23. Global Dystrophin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dystrophin Revenue Market Share by Region (2026-2031)
 Table 25. North America Dystrophin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dystrophin Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Dystrophin Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Dystrophin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dystrophin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dystrophin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dystrophin Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Dystrophin Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Dystrophin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dystrophin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dystrophin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dystrophin Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Dystrophin Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Dystrophin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dystrophin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dystrophin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dystrophin Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Dystrophin Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Dystrophin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dystrophin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dystrophin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dystrophin Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Dystrophin Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Dystrophin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dystrophin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dystrophin Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Dystrophin Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Dystrophin Sales Market Share by Type (2020-2025)
 Table 53. Global Dystrophin Sales Market Share by Type (2026-2031)
 Table 54. Global Dystrophin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dystrophin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dystrophin Revenue Market Share by Type (2020-2025)
 Table 57. Global Dystrophin Revenue Market Share by Type (2026-2031)
 Table 58. Global Dystrophin Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Dystrophin Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Dystrophin Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Dystrophin Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Dystrophin Sales Market Share by Application (2020-2025)
 Table 63. Global Dystrophin Sales Market Share by Application (2026-2031)
 Table 64. Global Dystrophin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dystrophin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dystrophin Revenue Market Share by Application (2020-2025)
 Table 67. Global Dystrophin Revenue Market Share by Application (2026-2031)
 Table 68. Global Dystrophin Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Dystrophin Price (USD/Pcs) by Application (2026-2031)
 Table 70. Asklepios BioPharmaceutical Inc Company Information
 Table 71. Asklepios BioPharmaceutical Inc Description and Business Overview
 Table 72. Asklepios BioPharmaceutical Inc Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Asklepios BioPharmaceutical Inc Dystrophin Product
 Table 74. Asklepios BioPharmaceutical Inc Recent Developments/Updates
 Table 75. BioMarin Pharmaceutical Inc Company Information
 Table 76. BioMarin Pharmaceutical Inc Description and Business Overview
 Table 77. BioMarin Pharmaceutical Inc Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. BioMarin Pharmaceutical Inc Dystrophin Product
 Table 79. BioMarin Pharmaceutical Inc Recent Developments/Updates
 Table 80. Daiichi Sankyo Company Ltd Company Information
 Table 81. Daiichi Sankyo Company Ltd Description and Business Overview
 Table 82. Daiichi Sankyo Company Ltd Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Daiichi Sankyo Company Ltd Dystrophin Product
 Table 84. Daiichi Sankyo Company Ltd Recent Developments/Updates
 Table 85. Editas Medicine Inc Company Information
 Table 86. Editas Medicine Inc Description and Business Overview
 Table 87. Editas Medicine Inc Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Editas Medicine Inc Dystrophin Product
 Table 89. Editas Medicine Inc Recent Developments/Updates
 Table 90. Genethon SA Company Information
 Table 91. Genethon SA Description and Business Overview
 Table 92. Genethon SA Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Genethon SA Dystrophin Product
 Table 94. Genethon SA Recent Developments/Updates
 Table 95. Nippon Shinyaku Co Ltd Company Information
 Table 96. Nippon Shinyaku Co Ltd Description and Business Overview
 Table 97. Nippon Shinyaku Co Ltd Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Nippon Shinyaku Co Ltd Dystrophin Product
 Table 99. Nippon Shinyaku Co Ltd Recent Developments/Updates
 Table 100. Pfizer Inc Company Information
 Table 101. Pfizer Inc Description and Business Overview
 Table 102. Pfizer Inc Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Pfizer Inc Dystrophin Product
 Table 104. Pfizer Inc Recent Developments/Updates
 Table 105. Sarepta Therapeutics Inc Company Information
 Table 106. Sarepta Therapeutics Inc Description and Business Overview
 Table 107. Sarepta Therapeutics Inc Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Sarepta Therapeutics Inc Dystrophin Product
 Table 109. Sarepta Therapeutics Inc Recent Developments/Updates
 Table 110. WAVE Life Sciences Ltd Company Information
 Table 111. WAVE Life Sciences Ltd Description and Business Overview
 Table 112. WAVE Life Sciences Ltd Dystrophin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. WAVE Life Sciences Ltd Dystrophin Product
 Table 114. WAVE Life Sciences Ltd Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Dystrophin Distributors List
 Table 118. Dystrophin Customers List
 Table 119. Dystrophin Market Trends
 Table 120. Dystrophin Market Drivers
 Table 121. Dystrophin Market Challenges
 Table 122. Dystrophin Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dystrophin
 Figure 2. Global Dystrophin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dystrophin Market Share by Type: 2024 & 2031
 Figure 4. DS-5141 Product Picture
 Figure 5. Biostrophin Product Picture
 Figure 6. BMBD-001 Product Picture
 Figure 7. NS-065 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Dystrophin Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Dystrophin Market Share by Application: 2024 & 2031
 Figure 11. Genetic Disorders
 Figure 12. Musculoskeletal Disorders
 Figure 13. Others
 Figure 14. Global Dystrophin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Dystrophin Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Dystrophin Sales (2020-2031) & (K Pcs)
 Figure 17. Global Dystrophin Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Dystrophin Report Years Considered
 Figure 19. Dystrophin Sales Share by Manufacturers in 2024
 Figure 20. Global Dystrophin Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Dystrophin Players: Market Share by Revenue in Dystrophin in 2024
 Figure 22. Dystrophin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Dystrophin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Dystrophin Sales Market Share by Country (2020-2031)
 Figure 25. North America Dystrophin Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Dystrophin Sales Market Share by Country (2020-2031)
 Figure 29. Europe Dystrophin Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Dystrophin Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Dystrophin Revenue Market Share by Region (2020-2031)
 Figure 37. China Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Dystrophin Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Dystrophin Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Dystrophin Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Dystrophin Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Dystrophin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Dystrophin by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Dystrophin by Type (2020-2031)
 Figure 59. Global Dystrophin Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Dystrophin by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Dystrophin by Application (2020-2031)
 Figure 62. Global Dystrophin Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Dystrophin Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Becker Muscular Dystropy Market Research Report 2025
Dystrophin ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytoskeleton Market Research Report 2024
Duchenne Muscular Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibroin Market Research Report 2024
Global Myosin Market Research Report 2024
Global Muscle Supplements Market Research Report 2024
Global Becker Muscular Dystrophy Drug Market Research Report 2024
Global Structural Proteins Market Research Report 2024
Global Dumbbell Market Research Report 2024
Menotrophin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global X protein Market Research Report 2024
Global Muscle Testing System Market Research Report 2024
Myotonic Muscular Dystrophy DMD Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Muscle Building Supplements Market Research Report 2024
Global Neurotrophins Market Research Report 2024
Global Steel Trading Market Research Report 2024
Global Human Skeletal Muscle Cells SkMC Market Research Report 2025
Global Chondroitin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Nutrition and Health Products Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions